Carcinogenesis
/ drug effects
Cell Line, Tumor
Cell Proliferation
/ drug effects
Epithelium
/ drug effects
Eukaryotic Initiation Factor-4G
/ genetics
Gene Expression Regulation, Neoplastic
/ drug effects
Humans
Mesothelioma, Malignant
/ genetics
Pleural Neoplasms
/ genetics
Quinazolines
/ pharmacology
RNA, Small Interfering
/ genetics
Small Molecule Libraries
/ pharmacology
beta Karyopherins
/ genetics
ran GTP-Binding Protein
/ genetics
EIF4G1
MPM
RAN
cancer driving gene
importazole
siRNA
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
09 Jul 2020
09 Jul 2020
Historique:
received:
15
05
2020
revised:
03
07
2020
accepted:
06
07
2020
entrez:
15
7
2020
pubmed:
15
7
2020
medline:
17
2
2021
Statut:
epublish
Résumé
For malignant pleural mesothelioma (MPM) novel therapeutic strategies are urgently needed. In a previous study, we identified 51 putative cancer genes over-expressed in MPM tissues and cell lines. Here, we deepened the study on nine of them (
Identifiants
pubmed: 32659970
pii: ijms21144856
doi: 10.3390/ijms21144856
pmc: PMC7402288
pii:
doi:
Substances chimiques
EIF4G1 protein, human
0
Eukaryotic Initiation Factor-4G
0
Quinazolines
0
RAN protein, human
0
RNA, Small Interfering
0
Small Molecule Libraries
0
beta Karyopherins
0
importazole
0
ran GTP-Binding Protein
EC 3.6.5.2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : Individual Grant nr. 21853
Références
JAMA Oncol. 2017 Jan 1;3(1):58-66
pubmed: 27584578
Blood. 2010 Mar 18;115(11):2127-35
pubmed: 20075156
Int J Clin Oncol. 2013 Oct;18(5):856-63
pubmed: 22956174
J Investig Dermatol Symp Proc. 2000 Dec;5(1):61-6
pubmed: 11147677
Mech Dev. 2005 Jul;122(7-8):865-76
pubmed: 15922571
Clin Transl Oncol. 2015 Jul;17(7):570-5
pubmed: 25740666
Int J Cancer. 2002 Mar 10;98(2):181-5
pubmed: 11857405
Oncol Res. 2013;21(2):67-72
pubmed: 24406042
J Cell Sci. 2006 Sep 1;119(Pt 17):3481-4
pubmed: 16931595
Mutat Res. 2012 Apr-Jun;750(2):132-40
pubmed: 22198210
Adv Biol Regul. 2012 May;52(2):326-39
pubmed: 22781746
Cancer Treat Rev. 2015 Jan;41(1):27-34
pubmed: 25467107
Diabetes Care. 1990 Mar;13(3):198-208
pubmed: 2407475
Sci Rep. 2018 May 10;8(1):7459
pubmed: 29748619
Mol Oncol. 2018 Nov;12(11):1856-1870
pubmed: 30221473
Clin Chem. 2009 Apr;55(4):611-22
pubmed: 19246619
Target Oncol. 2016 Oct;11(5):677-686
pubmed: 27023921
Stem Cells Int. 2018 Mar 15;2018:4217259
pubmed: 29736175
Genes Cancer. 2014 Apr;5(1-2):15-21
pubmed: 24955214
Oncotarget. 2016 Apr 26;7(17):24242-51
pubmed: 27003362
Am J Clin Pathol. 2014 Jan;141(1):85-93
pubmed: 24343741
Cancer Res. 2008 Mar 15;68(6):1826-33
pubmed: 18339863
Genes Cancer. 2017 Jan;8(1-2):438-452
pubmed: 28435517
ACS Chem Biol. 2011 Jul 15;6(7):700-8
pubmed: 21469738
PLoS One. 2016 Mar 16;11(3):e0150044
pubmed: 26982031
Eur Respir J. 1996 Sep;9(9):1932-42
pubmed: 8880114
Cancer Cell Int. 2019 Aug 31;19:224
pubmed: 31496918
Biochem Biophys Res Commun. 2013 Oct 18;440(2):322-9
pubmed: 24076388
J Biol Chem. 2011 Jul 22;286(29):25882-90
pubmed: 21613208
Ann Cardiothorac Surg. 2012 Nov;1(4):491-6
pubmed: 23977542
Mutat Res. 2015 Jan;771:6-12
pubmed: 25771974
Front Oncol. 2019 Jan 08;8:662
pubmed: 30671385
J Cell Mol Med. 2020 May;24(10):5565-5577
pubmed: 32301278
Adv Med Sci. 2019 Mar;64(1):104-110
pubmed: 30605863
Bull World Health Organ. 2011 Oct 1;89(10):716-24, 724A-724C
pubmed: 22084509
Endocr Relat Cancer. 2017 Mar;24(3):R49-R64
pubmed: 28159857
Mol Cancer. 2010 Apr 16;9:78
pubmed: 20398343